Yale-Waterbury Internal Medicine Residency, Yale University School of Medicine, Waterbury, Connecticut, USA.
Yale-Waterbury Internal Medicine Residency, Yale University School of Medicine, Waterbury, Connecticut, USA
BMJ Case Rep. 2022 Jun 27;15(6):e249873. doi: 10.1136/bcr-2022-249873.
A middle-aged woman presented with a mechanical fall. Physical examination revealed a massive purulent ulcerated lesion spanning her entire back and axilla, which had reportedly been brewing for over a decade. Punch biopsy revealed infiltrative basal cell carcinoma. She was treated with Vismodegib, with a remarkable decrease in the size of the cancer. However, surveillance imaging after 6 months of treatment revealed new bone metastases. In the setting of progressive disease, medical therapy was switched to cemiplimab instead. Basal cell carcinoma is commonly known as a benign tumour of the skin, rarely larger than 5 cm. Here, we discuss the entity of metastatic super giant basal cell carcinoma; this case is one of the largest reported lesions. As locoregional therapy, such as surgery is sometimes not appropriate for such advanced lesions, we discuss the current forefront of therapy including oral hedgehog pathway and check point inhibitors.
一位中年女性因机械性跌倒而就诊。体格检查发现其整个背部和腋窝有一处巨大的脓性溃疡性病变,据称已经存在十多年了。打孔活检显示浸润性基底细胞癌。她接受了维莫德吉治疗,癌症的大小显著缩小。然而,治疗 6 个月后的监测影像显示出现新的骨转移。在疾病进展的情况下,将药物改为西妥昔单抗。基底细胞癌通常被认为是一种皮肤良性肿瘤,很少超过 5 厘米。在这里,我们讨论转移性超级巨大基底细胞癌的实体;这是报道的最大病变之一。由于局部区域治疗,如手术有时不适合如此晚期的病变,我们讨论了目前包括口服 hedgehog 通路和检查点抑制剂在内的治疗前沿。